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Case of chest-wall rigidity in a preterm infant caused by prenatal
fentanyl administration
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The inability to appropriately ventilate neonates shortly after their birth
could be related in rare cases to chest-wall rigidity caused by the placental
transfer of fentanyl. Although this adverse effect is recognized when fentanyl
is administered to neonates after their birth, the prenatal phenomenon is
less known. Treatment with either naloxone or muscle relaxants reverses
the fentanyl effect and may prevent unnecessary excessive ventilatory
settings.
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Introduction
Fentanyl is used as a sedative and an analgesic in the care of
critically ill infants. Its most known side effect is respiratory
depression. A recognized uncommon side effect of fentanyl is
muscle and chest wall rigidity. Reports on this phenomenon caused
by prenatal fentanyl exposure are rare, when used in critically ill
mothers. We report a case of a preterm infant born with chest-wall
rigidity caused by intrauterine exposure to a high dose of fentanyl
that resolved after naloxone treatment.
Case report
This infant was delivered by an emergent cesarean section at
28 weeks’ gestation by an 18-year-old woman who was admitted
12h earlier to the respiratory intensive care unit with
pyelonephritis and adult respiratory distress syndrome. Despite
treatment with broad-spectrum antibiotics, intravenous ﬂuids and
inotropes, her hemodynamic and respiratory condition continued
to deteriorate. To control her respiratory function better, she was
ventilated and treated with a high dose of fentanyl
(20mcg
1kg
1h
1); however, no respiratory improvement was
achieved, and it was decided to perform a cesarean section.
The female infant (birth weight 1220g) was born apneic and
hypotonic, and needed immediate intubation and ventilation.
Surfactant (Curosurf-100mgkg
1) was administered via the
endotracheal tube, which was placed at 7.2cm attached to the
upper lip. Clinical evaluation upon arrival to the neonatal
intensive care unit at 15min after birth showed normal heart rate,
peripheral pulses and blood pressure, normal fontanelle, and equal
air entry to both lungs upon ventilation. No spontaneous
respirations were detected and the chest moved only with response
to high pressure (positive inspiratory pressure 25cm H2O, positive
end expiratory pressure 6cm H2O) via Neopuff. Chest X-ray
performed at 30min of age showed respiratory distress syndrome
without air leaks and correct position of the endotracheal tube. On
connecting to the ventilator, she developed recurrent de-saturation
episodes and periodic cessations in the chest-wall elevation
requiring frequent bag-assisted ventilation. Mean airway pressure
was gradually increased to 16cm H2O via different ventilation
modes (conventional mechanical ventilation and high-frequency
ventilation) without achieving adequate chest expansion. Arterial
blood gases showed worsening respiratory acidosis. The infant
remained hypotonic. No seizure activity was observed. At age 2h, in
view of chest-wall rigidity combined with generalized hypotonia, we
postulated adverse effects of placental transfer of fentanyl.
Accordingly, 0.1mgkg
1 naloxone was administered. Within
minutes the infant started to breathe and move her limbs. From
this point onwards, ventilation and oxygenation were easily
accomplished and it was possible to rapidly decrease the ventilation
parameters to a minimum with no episodes of de-saturation or
difﬁculties in chest expansion. The infant was extubated 2 days
after birth and was discharged from the neonatal intensive care
unit 56 days after birth. Cranial ultrasound evaluations on day 3,
at 1 week of age and before discharge were normal. Subsequent
developmental course and neurological examination at 6 months
after birth were normal.
Discussion
Fentanyl, one of the potent systemic opioids used for maternal
analgesia during labor, readily crosses the placenta,
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3 When
administered to the neonate, potential adverse effects are
respiratory depression, de-saturation episodes, lower heart rate and
sleep-state disturbances.
3 Less frequently seen are the
neuromuscular adverse effects of fentanyl, including abnormal
muscle movements, such as sucking or tonic–clonic movements,
but also laryngeal spasm and chest-wall rigidity in up to 4% of the
treated term and preterm infants even when low doses of fentanyl
are given.
4 The exact mechanism of muscle rigidity induced by
fentanyl is still unknown.
5
Information on the neonatal pharmacokinetics of placentally-
transferred fentanyl shortly after birth is limited.
1,6 Moreover, it has
been recently shown that there is a positive correlation between a
higher rate of fentanyl clearance after birth, and advanced
gestational age and birth weight, whereas in preterm infants the
clearance spectrum is very wide mainly because of hepatic
immaturity.
7 Therefore, extremely preterm infants are at an
increased risk of chest-wall rigidity induced by the placental
fentanyl transfer.
To our knowledge this is the third reported case of chest-wall
rigidity described in a preterm infant after maternal administration
of fentanyl before (as in our case) or during cesarean section. In
the case described by Lindemann,
8 extremely high ventilation
pressures (positive inspiratory pressures of 60 to 70cm H2O) were
required to inﬂate the lungs of a 31 weeks’ gestation neonate, while
increase in chest wall compliance was achieved only after the
infusion of naloxone and pancoronium. By a similar placental
fentanyl transfer mechanism, Bolisetty et al.
9 reported the
occurrence of chest-wall rigidity in a term infant after maternal
intrathecal administration of fentanyl before elective cesarean
section.
The cases reporting the possibility of neonatal chest-wall rigidity
after prenatal fentanyl administration emphasize the importance of
recognition and diagnosis of this phenomenon that may prevent
unnecessary barotrauma. Thus, in all cases of chest-wall rigidity
shortly after birth, the possibility of placental transfer of fentanyl
may be raised and treatment may be considered.
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